PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 114 filers reported holding PROVENTION BIO INC in Q3 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $12,267 | +190.1% | 509 | +27.2% | 0.00% | +100.0% |
| Q4 2022 | $4,228 | +111.4% | 400 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -33.3% | 400 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | -50.0% | 400 | -63.3% | 0.00% | -100.0% |
| Q4 2021 | $6,000 | +100.0% | 1,090 | +172.5% | 0.00% | – |
| Q3 2021 | $3,000 | -57.1% | 400 | -53.7% | 0.00% | -100.0% |
| Q2 2021 | $7,000 | -41.7% | 864 | -21.5% | 0.00% | -80.0% |
| Q1 2021 | $12,000 | -29.4% | 1,100 | +10.0% | 0.01% | -37.5% |
| Q4 2020 | $17,000 | +30.8% | 1,000 | 0.0% | 0.01% | +60.0% |
| Q3 2020 | $13,000 | +18.2% | 1,000 | +25.0% | 0.01% | 0.0% |
| Q2 2020 | $11,000 | +57.1% | 800 | 0.0% | 0.01% | +66.7% |
| Q1 2020 | $7,000 | -53.3% | 800 | -20.0% | 0.00% | -50.0% |
| Q4 2019 | $15,000 | +200.0% | 1,000 | +25.0% | 0.01% | +200.0% |
| Q3 2019 | $5,000 | +400.0% | 800 | +700.0% | 0.00% | – |
| Q2 2019 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 417,092 | $5,351,000 | 3.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 574,973 | $7,377,000 | 1.48% |
| Soleus Capital Management, L.P. | 139,418 | $1,789,000 | 0.95% |
| 683 Capital Management, LLC | 859,314 | $11,025,000 | 0.81% |
| Perceptive Advisors | 4,265,711 | $54,729,000 | 0.80% |
| GILDER GAGNON HOWE & CO LLC | 2,151,402 | $27,602,000 | 0.17% |
| Virtus ETF Advisers LLC | 21,485 | $276,000 | 0.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 230,873 | $2,962,000 | 0.12% |
| Windsor Creek Advisors, LLC | 28,492 | $366,000 | 0.10% |
| Newbridge Financial Services Group, Inc. | 6,500 | $83,000 | 0.08% |